Cargando…
Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
Age- related Macular Degeneration (AMD) is the leading cause of severe visual impairment in people 65 years and older in industrialized nations. Exudative, or “wet”, AMD is a late form of AMD (as distinguished from atrophic, so-called dry, AMD) and is responsible for over 60% of all cases of blindne...
Autores principales: | Garba, Adinoyi O., Mousa, Shaker A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661434/ https://www.ncbi.nlm.nih.gov/pubmed/23861616 http://dx.doi.org/10.4137/OED.S4878 |
Ejemplares similares
-
Pegaptanib in the treatment of wet, age-related macular degeneration
por: Vinores, Stanley A
Publicado: (2006) -
Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration
por: Thomas, Michael, et al.
Publicado: (2013) -
Future Therapies of Wet Age-Related Macular Degeneration
por: Ishikawa, Makoto, et al.
Publicado: (2015) -
Imaging of Wet Age-Related Macular Degeneration
por: Kenan, Damer
Publicado: (2016) -
Wet age related macular degeneration management and follow-up
por: Alexandru, Malciolu Radu, et al.
Publicado: (2016)